Clinical trial · Interventional
Magnetic Resonance Imaging of Breast Cancer
NCT01035112CI-TRIAL-00116578recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Breast Cancer Non-invasive Breast Cancer | Breast Neoplasm | PROBABILISTIC | 0.70 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MRI | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Magnetic Resonance Imaging (MRI) of Breast Cancer
- description
- Contrast-enhanced magnetic resonance imaging (MRI) using the standard department of Radiology MRI screening procedures. The duration of scanning may be variable, but will not exceed 90 minutes.
- interventionNames
- Procedure: MRI
Primary outcomes (1)
- measure
- To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
- timeFrame
- Length of one MRI scan
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
Show eligibility criteria text
INCLUSION CRITERIA * Female * Documented breast physical examination, * Documented mammography within 3 months of the MR studies * Palpable or mammographically-detected suspect breast lesions * Women who have already undergone lumpectomy for breast cancer and have post-biopsy/post-radiation changes will be eligible if they have mammographically-detected or palpable breast abnormalities which are sufficiently suspicious to merit core needle or surgical biopsy. EXCLUSION CRITERIA: * Male by birth * Able to complete the MR examination. Subjects will be interviewed by one of the investigators for the usual contraindications to * MR contraindications including * Pacemakers * Metallic implants * Severe claustrophobia * Aneurysm clips * Pregnancy * Current lactation * Other conditions precluding proximity to a strong magnetic field. * Received an enhanced MR procedure within 48 hours, * Iodinated contrast within six hours, * Known sensitivity to MR contrast agents, * Not likely to complete the study in full or * Other clinical reason which would preclude participation in the protocol.
References
Publications (0)
Data not yet available
No reference posted for this study.